Abstracts

  • Abstracts are now being accepted for the 3rd Canadian Stroke Congress until April 16, 2012.  Accepted abstracts will be published in the journal Stroke online at the time of the Congress.

    Please click here to access the online abstract submission system.

    Abstract Submission Guidelines

    • Abstracts are welcome from national and international applicants from all disciplines. Authors may submit multiple abstracts.
    • Abstracts may be submitted in English or French and presentations at the Congress may be given in either language.
    • Presenters must register for the Congress and will be required to pay the appropriate registration fee.
    • Applicants should categorize their abstract based on one of the six subject area categories provided in the abstract submission system.
    • Applicants should indicate the format they would prefer to present their abstracts:
    1. Oral: A 10-minute oral presentation in a plenary or breakout session.  Spaces are limited.  Those who are not successful in securing an oral presentation slot will be offered to present their abstract via a mini-platform or display poster format.
    2. Oral Poster:  A digital poster.  Presenters will have the opportunity to briefly present their poster during a moderated session.  Digital posters will be available for viewing to all Congress delegates throughout the Congress.
    3. Display Poster: A traditional paper (non-digital) poster.  Presenters will be asked to be available to answer questions during set times during the Congress.  Display posters will be available for viewing to all Congress delegates throughout the Congress.
    • All abstracts will be peer-reviewed with the exception of those categorized as ongoing clinical trials. Ongoing clinical trials will only be accepted as display posters.
    • Each abstract should be a maximum of 300 words (excluding title and authors) and should consist of four separate paragraphs:
    1. Background: briefly describing the problem or issue being addressed
    2. Methods: describing how the study was performed
    3. Results: describing the salient results or findings
    4. Conclusions: describing what the authors conclude from these results.
    • Research presented in abstracts must conform to CIHR guidelines for experimental procedures. All investigations involving humans and animals must have been conducted in conformity with these principles.
    • Authors must declare any financial interest in a company (or its competitors) that makes a product discussed in the abstract.

    Applicants should categorize their abstract based on one of the six subject area categories provided in the abstract submission system.
    These include:

    • Prevention (Primary and Secondary)
    • Acute Interdisciplinary Management
    • Comprehensive In-Patient Rehabilitation
    • Long Term Management/Rehabilitation
    • Basic Biomedical
    • Ongoing Clinical Trials (Poster Only)

     

  • Thank you!

     

    • CSN
    • HSFC
    • csc
    • Bayer
    • Boehringer_Ingelheim
  • Key Dates

     

    February 13, 2012
    Abstract submission opens
    March 12, 2012
    Preliminary program available online
    April 16, 2012
    Abstract submission closes
    May 17, 2012
    Registration and accommodation opens
    June 8, 2012
    Late breaking and featured clinical trials submission deadline
    August 3, 2012
    Early bird registration closes
    September 24, 2012
    Online registration closes
  • Latest Tweets

     

    CDN Stroke Congress: Early-bird registration for the 2012 Canadian Stroke Congress begins Thursday (May 17). Learn more http://t.co/ChjgjbAq 3 days ago

    CDN Stroke Congress: Speakers come from around the world to present at the 2012 Canadian Stroke Congress. Read more in Brainwaves http://t.co/4rqZmZ9v 8 days ago

    CDN Stroke Congress: 2012 Canadian Stroke Congress registration opens in ONE week (May 15) http://t.co/vVooyt9w 10 days ago

    Join the conversation

Switch to our mobile site